Strategy Inc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Strategy Inc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $463.46M | Feb 18, 2025 |
| FY2024 | Dec 31, 2023 | $496.26M | Feb 18, 2025 |
| FY2024 | Dec 31, 2022 | $499.26M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $510.76M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $480.74M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $486.33M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $497.64M | Feb 12, 2021 |
| FY2017 | Dec 31, 2017 | $138.15M | Feb 7, 2018 |
| FY2017 | Sep 30, 2017 | $125.21M | Feb 7, 2018 |
| FY2017 | Jun 30, 2017 | $120.61M | Feb 7, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $477.23M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $463.46M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $496.26M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $499.26M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $510.76M | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | $131.32M | Feb 12, 2021 |
| FY2020 | Sep 30, 2020 | $127.41M | Feb 12, 2021 |
| FY2020 | Jun 30, 2020 | $110.58M | Feb 12, 2021 |
| FY2020 | Mar 31, 2020 | $111.42M | Feb 12, 2021 |
| FY2020 | Dec 31, 2019 | $133.53M | Feb 12, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $327.82M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $333.99M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $386.32M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $396.28M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $418.85M | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | $110.53M | Feb 12, 2021 |
| FY2020 | Sep 30, 2020 | $105.67M | Feb 12, 2021 |
| FY2020 | Jun 30, 2020 | $86.60M | Feb 12, 2021 |
| FY2020 | Mar 31, 2020 | $86.88M | Feb 12, 2021 |
| FY2020 | Dec 31, 2019 | $108.90M | Feb 12, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.85B) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($1.17B) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $429.12M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | ($1.47B) | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | ($535.48M) | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | $2.66M | Feb 12, 2021 |
| FY2020 | Sep 30, 2020 | ($14.23M) | Feb 12, 2021 |
| FY2020 | Jun 30, 2020 | $3.39M | Feb 12, 2021 |
| FY2020 | Mar 31, 2020 | $657.0K | Feb 12, 2021 |
| FY2020 | Dec 31, 2019 | $12.17M | Feb 12, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($5.44B) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($1.85B) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | ($115.05M) | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | ($1.28B) | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | ($784.53M) | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | ($13.63M) | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | ($1.00M) | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $3.98M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $73.22M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $109.51M | Feb 20, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $93.86M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $118.49M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $120.53M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $127.43M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $117.12M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $103.56M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $109.42M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $102.50M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $78.77M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $73.14M | Feb 20, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($67.24M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($53.03M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $12.71M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $3.21M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $93.83M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $53.62M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $60.87M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $10.63M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $78.32M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $110.59M | Feb 20, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.21M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.98M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $2.94M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $2.49M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $2.71M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $3.65M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $10.18M | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $6.85M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $3.98M | Feb 14, 2020 |
| FY2018 | Dec 31, 2016 | $2.34M | Feb 20, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $61.64B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $25.84B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $4.76B | Feb 19, 2026 |
| FY2023 | Dec 31, 2022 | $2.41B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $3.56B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $1.47B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $916.57M | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $855.77M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $933.22M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $768.32M | Feb 7, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.60B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $7.61B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $2.60B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $2.79B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $2.58B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $912.57M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $408.01M | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $326.04M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $327.49M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $216.14M | Feb 7, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.12B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $18.23B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $2.16B | Feb 19, 2026 |
| FY2025 | Dec 31, 2022 | ($383.12M) | Feb 19, 2026 |
| FY2024 | Dec 31, 2021 | $978.96M | Feb 18, 2025 |
| FY2023 | Dec 31, 2020 | $446.19M | Feb 15, 2024 |
| FY2022 | Dec 31, 2019 | $508.56M | Feb 16, 2023 |
| FY2021 | Dec 31, 2018 | $529.73M | Feb 16, 2022 |
| FY2020 | Dec 31, 2017 | $605.73M | Feb 12, 2021 |
| FY2019 | Dec 31, 2016 | $566.32M | Feb 14, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.32B | Feb 19, 2026 |
| FY2025 | Jan 1, 2025 | $10.58B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($2.17B) | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | ($999.23M) | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | ($1.43B) | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $41.44M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $575.97M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $583.49M | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $549.13M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $526.63M | Feb 20, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.30B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $38.12M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $46.82M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $43.84M | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $63.36M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $59.68M | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $456.73M | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $109.92M | Feb 14, 2020 |
| FY2018 | Dec 31, 2017 | $420.24M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $401.98M | Feb 7, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.19B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $7.19B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $2.18B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $2.38B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $2.16B | Feb 16, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (15) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | (6) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | (12) | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | (53) | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 12, 2021 |
| FY2020 | Sep 30, 2020 | (1) | Feb 12, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 12, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 12, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 12, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (15) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | (6) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | (12) | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | (53) | Feb 15, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 12, 2021 |
| FY2020 | Sep 30, 2020 | (1) | Feb 12, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 12, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 12, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 12, 2021 |